Skip to main content

Hand Me Down Genes


In 1994, at age 27, Keira Berman became acutely ill with what she thought was the flu. She also had blood in her stool, an issue she had dealt with since childhood and assumed to be a reaction to certain foods. Berman’s physician sent her to a gastroenterologist, who detected thousands of polyps in her colon via colonoscopy.

Neither her gastroenterologist nor his pathologist knew what the polyps were, so they sent slides to several universities, Berman recalls. Johns Hopkins University responded that, based on her age and the number of polyps in her colon, the New Jersey resident likely had a relatively rare hereditary syndrome known as familial adenomatous polyposis (FAP).

The impact of the diagnosis was dramatic. Informed that the polyps in her colon would likely become cancerous soon, Berman underwent a total colectomy and ileoanal anastomosis surgery to construct a J pouch for waste elimination. In the years that followed, FAP affected almost every aspect of her life, from the foods she could eat to her decision to have a family.

Read More:  http://www.curetoday.com/publications/cure/2015/colorectal-cancer-special-issue/Hand-Me-Down-Genes

Comments

Unknown said…
Hi. My mother lost a sister at 36 years to endometrial cancer in the 1980s and over the next twenty years lost over a dozen first cousins to cancer, mostly colon cancer. In 2012, in her early 60s, my mother was diagnosed with endometrial cancer and tested for HNPCC, which she was said to have. I, too, had genetic testing and have been told that I have a variant of "uncertain significance," but my mom's doctor says I have the same mutation that she has. I know mine is MSH2 and the mutation is F394L. Since I know my family history, shouldn't I treat this as a variant likely to lead to cancer? How can I be certain our family information is included in the research? My mother is treated at the Rockefeller Cancer Center in Little Rock, AR, and I live in the Kansas City area. I have two siblings and two children, and one of my siblings has two children. Only my mother and I have been tested. You can reach me at the gmail below or 913.240.5343.

This is what I can find about it from NCBI:
"This variant is denoted MSH2 c.1182T>G at the cDNA level, p.Phe394Leu (F394L) at the protein level, and results in the change of a Phenylalanine to a Leucine (TTT>TTG) in exon 7. This variant has not, to our knowledge, been published in the literature as either a mutation or a benign polymorphism. MSH2 Phe394Leu was not observed at a significant allele frequency in the NHLBI Exome Variant Server. This variant is a conservative substitution of one neutral non-polar amino acid for another, altering a position that is well conserved throughout evolution and is located in the Lever domain and the region of interaction with MSH6 and MSH3 (Lutzen 2008). In silico analyses are inconsistent with regard to the effect this variant may have on protein structure and function. Based on the currently available information, we consider MSH2 Phe394Leu to be a variant of unknown significance. The variant is found in BR-OV-HEREDIC,HEREDICANCER panel(s)."
Anonymous said…
If you have same gene mutation as your mom and she had cancer it is most likely yours is a mutation that is not benign. At the time I was tested I don't think they knew which ones were or not but I had cancer and I had the mutation on the second chromosome. Then we tested the rest of the family for that specific mutation. If your mom had cancer and the mutation. And you do too the rest of your family should whether or not the research has evidence because a new mutation could have occurred. Your cousins hopefully got tested too?
Ivy

Popular posts from this blog

Get the Facts About Genetic Colon Cancer

Get the Facts: http://genefacts.org Lynch syndrome is a cancer predisposition syndrome caused by inherited mutations in genes responsible for correcting DNA replication errors. Individuals with Lynch syndrome have a greatly increased risk for colorectal, endometrial, and stomach cancers, and a moderately increased risk for other cancers. Key Points 1-3% of colon cancers attributable to Lynch syndrome Dominant inheritance with reduced penetrance (not all patients with mutations will manifest disease) Diagnosis based on clinical and family history, tumor pathology and/or genetic testing Screening and prophylactic surgeries effective in reducing some, but not all cancer risks Mutations in any of several genes can cause the syndrome

Cancer Survivors

Just read a story about one woman's cancer experience. I bet everyone has a story about what goes through your mind when you are told you have cancer. Her thought were about her stunned family members, one crying and the other in shock. I bet there are quite a few stories that could be qualitatively studied. Those experiences could help nurses better help patients during this time.

My Publication, "Hereditary non-polyposis colon cancer: change the name to protect the innocent." Cited in World Journal of Gastroenterology

Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration t... Hsi-Hsien Hsu, Wei-Wen Kuo, Da-Tong Ju... World journal of gastroenterology : WJG 11/2014 20(44):16665-73. World Journal of Gastroenterology : WJG 11/2014; 20(44):16665-73. DOI: 10.3748/wjg.v20.i44.16665 Source: PubMed ABSTRACT To investigate the effects of 17β-estradiol via estrogen receptors (ER) or direct administration of ER agonists on human colorectal cancer. LoVo cells were established from the Bioresource Collection and Research Center and cultured in phenol red-free DMEM (Sigma, United States). To investigate the effects of E2 and/or ER selective agonists on cellular proliferation, LoVo colorectal cells were treated with E2 or ER-selective agonists for 24 h and 48 h and subjected to the MTT (Sigma) assay to find the concentration. And investigate the effects of E2 and/or ER selective agonists on cell used western immunoblotting to find out the diver...